Price $3.21 |
Market Cap
381.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
0.03
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
364K
|
FCF
-1.9
|
|
Op. Margin
-12.60%
|
Net Margin
-16.20%
|
ROE
747.40%
|
ROI
-10.90%
|
|
ROA
-12.70%
|
EPS Growth
-252.50%
|
Current Ratio
1.7
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Opiant Pharmaceuticals Inc (OPNT) | $15.40 | - | - | 38.5M | Strong Buy |
| Aralez Pharmaceuticals Inc (ARLZ) | $0.05 | - | - | 21.8M | Strong Buy |
| Kalvista Pharmaceuticals Inc (KALV) | $12.76 | - | - | 86.4M | Strong Buy |
| Mannatech, Inc. (MTEX) | $20.20 | - | 2.60% | 52.3M | Strong Buy |
| AMAG Pharmaceuticals, Inc. (AMAG) | $24.80 | - | - | 772.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
